Attune
PrivateLast Round
Growth Equity
Jan 27, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Attune operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Growth Equity round in January 2026.
Attune is a healthcare technology company that provides an agentic voice platform to automate patient and member communications for providers and payors.
Sector
Healthcare & Life Sciences
Verticals
NLP & Conversational AI, Patient Engagement, Vertical SaaS, Workflow Automation, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attune Comparables
Compare Attune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hyro | 86% | |
| Assort Health | 86% | |
| Hippocratic AI | 86% |
For institutional investors. Book with your work email.
Attune Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Attune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chicago Pacific Founders | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
Grew 19% QoQ, from 47 to 56 employees.
- Jul 23, 2026
Grew 23% QoQ, from 43 to 53 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 29, 2026
Kyle Yamaguchi has joined Attune as VP of partnerships and growth strategy after serving as an associate at CVS Health Ventures.
For institutional investors. Book with your work email.
Attune Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Attune's valuation, stock price, and market status.
Is Attune a public or private company?
Attune is a private company.
What is the current stock price of Attune?
Attune is a private company, so its shares have no public market price. Caplight tracks Attune's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Attune worth (valuation)?
Valuation information for Attune is not publicly available.
Can I buy Attune stock?
Attune shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Attune's last funding round?
Attune's most recent funding round was Growth Equity on January 27, 2026.
Who are the main investors in Attune?
Key investors in Attune include Chicago Pacific Founders.
Will Attune IPO soon?
No public IPO plans have been announced for Attune.
How can I track Attune secondary market activity?
Caplight tracks bids, offers, and trades in Attune's shares on secondary markets.